Clinical Trial Update: A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study of MK-7655A in pediatric participants with suspected or documented Gram-negative bacterial infections has completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infection

Drugs mentioned

• MK-7655A (MK-7655A)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Suspected or Documented Gram-negative Bacterial Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-12-13